Warfarin Genotyping Reduces Hospitalization Rates: Results From the MM-WES (Medco-Mayo Warfarin Effectiveness Study)
Top Cited Papers
- 22 June 2010
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 55 (25), 2804-2812
- https://doi.org/10.1016/j.jacc.2010.03.009
Abstract
No abstract availableFunding Information
- Mayo Clinic Center for Individualized Medicine and Medco Health Solutions
This publication has 24 references indexed in Scilit:
- Increased Ambulatory Care Copayments and Hospitalizations among the ElderlyThe New England Journal of Medicine, 2010
- Warfarin Sensitivity Genotyping: A Review of the Literature and Summary of Patient ExperienceMayo Clinic Proceedings, 2009
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic DataThe New England Journal of Medicine, 2009
- The largest prospective warfarin-treated cohort supports genetic forecastingBlood, 2009
- CYP4F2 genetic variant alters required warfarin doseBlood, 2008
- Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of WarfarinClinical Pharmacology & Therapeutics, 2008
- Randomized Trial of Genotype-Guided Versus Standard Warfarin Dosing in Patients Initiating Oral AnticoagulationCirculation, 2007
- Bleeding Complications With Warfarin UseArchives of Internal Medicine, 2007
- Association of warfarin dose with genes involved in its action and metabolismHuman Genetics, 2006
- Effect ofVKORC1Haplotypes on Transcriptional Regulation and Warfarin DoseThe New England Journal of Medicine, 2005